The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | M | Musculo-skeletal system | |
| 2 | M01 | Antiinflammatory and antirheumatic products | |
| 3 | M01C | Specific antirheumatic agents | |
| 4 | M01CC | Penicillamine and similar agents |
| Code | Title | |
|---|---|---|
| M01CC01 | Penicillamine | |
| M01CC02 | Bucillamine |
| Active Ingredient | Description | |
|---|---|---|
| Bucillamine |
|
|
| Penicillamine |
Penicillamine is a chelating agent which aids the elimination from the body of certain heavy metal ions, including copper, lead and mercury, by forming stable soluble complexes with them that are readily excreted by the kidney. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| CUPRIMINE Capsule | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
| PENICILLAMINE Film-coated tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
